LEASE AGREEMENTLease Agreement • August 9th, 2004 • NPS Pharmaceuticals Inc • Biological products, (no disgnostic substances) • Ontario
The undermentioned is a summary of some of the essential terms of this lease. For details of the terms and meanings of the terms referred to below, recourse should be had to the balance of this lease. This summary is for convenience only and if a conflict occurs between the provisions of this summary and any other provisions of this lease, the other provisions of this lease shall govern.
FIRST AMENDMENT TO DISTRIBUTION AND LICENSE AGREEMENTDistribution and License Agreement • August 9th, 2004 • NPS Pharmaceuticals Inc • Biological products, (no disgnostic substances)
THIS FIRST AMENDMENT TO DISTRIBUTION AND LICENSE AGREEMENT (the “Amendment”) is made and entered into on the 1st day of July, 2004 (the “Effective Date”), by and between NPS Allelix Corp. (“Licensor”), and Nycomed Danmark ApS (“Licensee”). Licensor and Licensee are referred to in this Amendment individually as a “Party” and collectively as the “Parties.”
EXTENSION AND ADDITIONAL SPACE AGREEMENTExtension and Additional Space Agreement • August 9th, 2004 • NPS Pharmaceuticals Inc • Biological products, (no disgnostic substances)
DISTRIBUTION AND LICENSE AGREEMENT Between NPS ALLELIX CORP. And NYCOMED DANMARK APS Dated APRIL 20, 2004Distribution and License Agreement • August 9th, 2004 • NPS Pharmaceuticals Inc • Biological products, (no disgnostic substances) • New York
THIS DISTRIBUTION AND LICENSE AGREEMENT (the “Agreement”) is made and entered into on the 20th day of April, 2004 (the “Effective Date”), by and between NPS ALLELIX CORP., a Canadian corporation (“Licensor”), having offices at 6850 Goreway Drive, Mississauga, Ontario, L4V IV7, Canada, and NYCOMEDDANMARK APS, a Danish corporation (“Licensee”), having offices at Langebjerg 1, DK-4000 Roskilde, Denmark. Licensor and Licensee are referred to in this Agreement individually as a “Party” and collectively as the “Parties.”
